ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
May 2025
Nuclear Technology
April 2025
Fusion Science and Technology
Latest News
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”
Tomohiko Asai, Fuji Kodera, Tomohiro Yoneda, Mamoru Okubo, Shigefumi Okada, Seiichi Goto
Fusion Science and Technology | Volume 39 | Number 1 | January 2001 | Pages 366-369
Poster Presentations | doi.org/10.13182/FST01-A11963482
Articles are hosted by Taylor and Francis Online.
The first experiments of neutral beam (NB) injection into a field-reversed configuration (FRC) plasma have been performed at FIX (FRC Injection Experiment) device.1 The experimental results show that the configuration lifetime of a FRC have been expanded by about 200% compared with no NB injection case. These results indicate that several hundred kilo watts of NB injection saves several mega watts of global energy losses. For understanding these experimental phenomena, some numerical calculations have been performed. Numerically calculated ionization degree vs. distance along beam injection axis and beam trajectories show that the injected beam ions form dense regions around minimum │B│. These formed hot beam ions walls would play a role in improving these confinements on the edge layer. Some previous theoretical studies pointed out the existence of electrostatic effects in the FRC edge plasma confinements.6, 7 Since only several kilo watts NB injection improves FRC confinement, it seems that the injected hot beam ions encourage electrostatic effects on the edge layer.
